Elekta AB (publ) (OTCMKTS:EKTAY) Reaches New 52-Week Low – Should You Sell?

Shares of Elekta AB (publ) (OTCMKTS:EKTAY) reached a new 52-week low on Tuesday . The company traded as low as $5.45 and last traded at $5.46, with a volume of 7902 shares traded. The stock had previously closed at $5.68.

Elekta AB (publ) Stock Performance

The firm has a market capitalization of $2.09 billion, a P/E ratio of 22.70 and a beta of 1.23. The company has a debt-to-equity ratio of 0.45, a current ratio of 0.99 and a quick ratio of 0.74. The firm has a 50-day moving average price of $6.05 and a two-hundred day moving average price of $6.31.

About Elekta AB (publ)

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.